95% of healthtech innovations never reach the market – and therefore the patients who desperately need them. NLC – The European Healthtech Venture Builder – has been working since 2015 with a network of over 3,000 experts from industry, research and medicine to reach these patients.
Pain monitoring systems, ultrasound cancer detection and light therapy for newborns: these are just a few of the more than 3,600 life-changing inventions that NLC evaluates annually and guides towards market maturity through a structured process.
The Dutch company has already successfully transformed more than 100 innovations into start-ups and supports them from foundation to financing and market entry.